Skip to content

AI-assisted Transcranial Duplex Sonography for Early Detection of Intracerebral Haemorrhage: HYPER-AI-SCAN

HYPER-AI-SCAN: HYPER-acute AI-assisted Sonographic Cerebral Hemorrhage Assessment Network

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07319013
Enrollment
500
Registered
2026-01-06
Start date
2025-03-14
Completion date
2027-06-30
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Haemorrhage, Intracerebral Hemorrhage, Intracerebral Hemorrhage Basal Ganglia, Stroke

Keywords

stroke, intracerebral hemorrage, Ischemic Stroke, Hemorrhagic Stroke, transcranial ultrasound, Transcranial Doppler, Portable Ultrasound, Neurosonology, Artificial Intelligence, Machine Learning, Diagnostic Accuracy, Prehospital Care, Feasibility Study, Deep Learning

Brief summary

The goal of this observational study is to evaluate whether transcranial Doppler ultrasound, combined with artificial intelligence (AI), can help identify intracerebral haemorrhage (ICH) in people with acute stroke (both men and women, adults of all ages) within 48 hours of symptom onset. The main questions it aims to answer are: Is it feasible to perform standardized protocol transcranial ultrasound in acute stroke patients? Can AI models trained on ultrasound images accurately distinguish haemorrhagic stroke (ICH suspected) from non-haemorrhagic stroke? There is no comparison group, because all participants will undergo both CT (as standard care) and ultrasound (research imaging), and the AI models will compare their ultrasound-based predictions against CT-confirmed diagnoses. Participants will: undergo a non-invasive transcranial ultrasound scan after CT confirms the type of stroke allow researchers to collect coded ultrasound images for AI model training provide clinical and imaging information (already collected as part of routine care) to help evaluate factors related to diagnostic accuracy No treatments or changes to clinical care will be introduced as part of the study.

Detailed description

Stroke is a medical emergency that can be caused either by a blocked blood vessel (ischaemic stroke) or by bleeding inside the brain (haemorrhagic stroke). These two types of stroke require very different treatments, and identifying which one is occurring as quickly as possible is essential. Currently, the only reliable way to distinguish between these two types of stroke is with a brain scan such as a CT scan. However, CT is not always available immediately, especially in prehospital settings or in hospitals without 24/7 imaging access. As a result, patients may experience delays before receiving the correct treatment. This study aims to explore whether a simple ultrasound scan of the brain, performed through the skull, can help identify haemorrhagic stroke more quickly. This technique is called transcranial Doppler ultrasound (TCD). It is fast, non-invasive, and uses no radiation. A total of 500 patients with suspected stroke within 48 hours of symptom onset will be included. After the standard CT scan confirms the diagnosis, each participant will undergo a brief ultrasound scan following a structured protocol. The ultrasound images will then be used to train and test artificial intelligence (AI) models, which will learn to recognize patterns associated with haemorrhagic stroke. These AI models will compare the ultrasound images with CT results and try to predict whether a bleed is present (ICH suspected) or not. The main goals of the study are: To determine whether portable ultrasound can be performed reliably and consistently in real stroke patients. To evaluate whether AI can support clinicians by interpreting these ultrasound images and distinguishing between haemorrhagic and non-haemorrhagic strokes. All other clinical information-such as symptoms, timing of arrival, and medical history-will also be collected to understand which factors may influence the performance of ultrasound and AI. Importantly, the ultrasound does not replace standard medical care and will not influence the treatment that patients receive. It is performed only for research purposes. The CT scan remains the reference test for diagnosis. By combining ultrasound with AI, this project hopes to pave the way for future systems capable of assisting paramedics or physicians in identifying haemorrhagic stroke earlier, especially in settings where CT is not immediately available. Earlier recognition may help reduce delays in blood pressure management or treatment reversal for patients taking anticoagulants.

Interventions

None listed

Sponsors

Hospital Universitari Vall d'Hebron Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (age ≥18 years). * Clinical diagnosis of acute stroke (ischemic or intracerebral hemorrhage). * Able to undergo transtemporal transcranial ultrasound according to the standardized protocol (no clinical instability) * Informed consent obtained from the patient or legally authorized representative, per local regulations.

Exclusion criteria

* Infratentorial hemorrhage (e.g., cerebellar or brainstem hemorrhage), due to limitations of transtemporal insonation. * Isolated subarachnoid hemorrhage without parenchymal involvement. * Hemodynamic instability or medical conditions requiring immediate life-saving intervention that preclude safe ultrasound recording. * Known skull defects or prior craniectomy on the side required for contralateral insonation. * Any condition that, in the opinion of the investigators, would interfere with protocol adherence or data accuracy.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of standardized transcranial ultrasound acquisition in acute strokeAt enrollment time (T0)Feasibility will be measured as the proportion of patients in whom a diagnostic-quality transcranial ultrasound window is obtained (window quality grade 1 or 2). All examinations will follow the same standardized acquisition protocol, ensuring methodological consistency across operators. Diagnostic window success rate (%) will serve as the primary outcome.

Secondary

MeasureTime frameDescription
Exam acquisition time under a standardized protocolAt enrollment time (T0)Time (in seconds) from probe placement to acquisition of the first diagnostic-quality sonographic frame, obtained using the standardized sonographic protocol. Results will be reported as median, interquartile range (IQR), and distribution.
Accuracy of AI-based classification of intracerebral haemorrhage using standardized TCD acquisitionsFrom enrollment to the completion of imaging data collection at 16 monthsEvaluation of artificial intelligence models (CNN and transformer-based architectures) trained on ultrasound images acquired with a uniform standardized protocol. Performance will be assessed against CT-confirmed diagnosis.

Other

MeasureTime frameDescription
Operator-level variability in acquisition performance using the standardized protocolAt enrollment time (T0)Comparison of diagnostic level images acquisition time across operators performing scans with the same standardized protocol. Results will evaluate reproducibility and ease of training.

Countries

Spain

Contacts

Primary ContactRENATO SIMONETTI, MD
renato.simonetti@vallhebron.cat+34934893000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026